A Comparative Clinical Trial to Evaluate the Safety and Clinical Equivalence of Clotrimazole Troche/Lozenges USP, 10mg (Unique Pharmaceutical Laboratories, India) With Clotrimazole Troche 10mg (Roxane Laboratories Inc., USA) in Subjects With Oropharyngeal Candidiasis.
Condition: Oropharyngeal CandidiasisIntervention: Drug: Clotrimazole troche/ lozenges, 10 mgSponsors: Thinq Pharma-CRO Pte. Ltd.; Unique Pharmaceuticals Ltd, India; Biosphere Clinical Research e-Prudent; THINQ Pharma CRO Ltd.Not yet recruiting - verified December 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 16, 2015 Category: Research Source Type: clinical trials
A Comparative Clinical Trial to Evaluate the Safety and Clinical Equivalence of Clotrimazole Troche/Lozenges USP, 10mg (Unique Pharmaceutical Laboratories, India) With Clotrimazole Troche 10mg (Roxane Laboratories Inc., USA) in Subjects With Oropharyngeal Candidiasis.
Condition: Oropharyngeal CandidiasisInterventions: Drug: Unique Pharmaceutical Laboratories, India; Drug: Roxane Laboratories Inc., USASponsors: Thinq Pharma-CRO Pte. Ltd.; Unique Pharmaceuticals Ltd, India; Biosphere Clinical Research e-Prudent; THINQ Pharma CRO Ltd.Not yet recruiting - verified December 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 16, 2015 Category: Research Source Type: clinical trials
Efficacy, Safety LactiSal 1% Gel, LactSal 50 mg, Clotrimazole 100 mg Tablet in Treatment Vulvovaginal Candidiasis
Condition: Vulvovaginal Candidiasis Interventions: Device: LactiSal vaginal gel 1%; Device: LactiSal vaginal tablet 50mg; Drug: Clotrimazole vaginal tablet 100mg Sponsor: Medinova AG Not yet recruiting - verified September 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 23, 2015 Category: Research Source Type: clinical trials
